, CEO of Sana Biotechnology, shares an update on Sana鈥檚 clinical pipeline including its work on blood cancers, and its additional focus on curing Type 1 diabetes. More from Flagship @ JPM2023 here.
Related Companies
- Sana Biotechnology Founded: 2018
More from:
Human Health
Three Questions with Junaid Bajwa, Flagship Senior Partner, Head of UK, and Science Partner for Pioneering Intelligence
The Future of Genetic Medicines is Here
Three Questions with Hari Pujar, Founding President of Mirai Bio and Flagship Operating Partner
The Next Generation of Biologics Are Supranatural
Pioneering Profile
Q&A with Molly Gibson on Leading Company Origination
Letter of Support
